Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YuWen Chen

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Plos One|November 4, 2025
The impact of ESG performance on corporate innovation-Empirical evidence from Chinese pharmaceutical listed companiesLiqiang Li, Su Wang, Yuwen Chen
Experimental Hematology & Oncology|March 16, 2021
Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopeniaYuwen Chen, Jianda Hu, Yingyu Chen
Therapeutic Innovation & Regulatory Science|November 23, 2023
Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future DirectionsPei Li, Su Wang, Yuwen Chen
Sensors (Basel, Switzerland)|December 31, 2025
Joint Learning of Emotion and Singing Style for Enhanced Music Style UnderstandingYuwen Chen, Jing Mao, Rui-Feng Wang
Frontiers in Public Health|January 20, 2025
Controlling shareholders' equity pledge and corporate innovation investment-empirical analysis based on pharmaceutical manufacturingJiawen Li, Xingyu Zhao, Su Wang, et al.
Scientific Reports|June 13, 2018
(-)-Gochnatiolide B, synthesized from dehydrocostuslactone, exhibits potent anti-bladder cancer activity in vitro and in vivoYuwen Chen, Wenhua Li, Zhongqiu Zeng, et al.
Frontiers in Medicine|April 17, 2026
The impact of the 2019 revision of China's drug administration law on the innovative output of pharmaceutical and biotechnology enterprises-a quasi-natural experimental study using sharp regression discontinuity designYanan Zhu, Yongfei Liu, Yuwen Chen, et al.
Cell Biology and Toxicology|August 1, 2025
CD44-targeted therapy using mP6/Rg3 micelles inhibits oral cancer stem cell proliferation and migrationSijia Cai, Yuwen Chen, Changyu Chen, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 22, 2024
[Rapamycin and HPPH Co-Loaded Nanodrug Delivered via Dissolvable Microneedles to Treat Port-Wine Stains]Ying Hao, Runhao Xu, Mao Chen, et al.
Tumour Virus Research|January 20, 2025
How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infectionYuwen Chen, Nagayasu Egawa, Ke Zheng, et al.
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Plos One|November 4, 2025
The impact of ESG performance on corporate innovation-Empirical evidence from Chinese pharmaceutical listed companiesLiqiang Li, Su Wang, Yuwen Chen
Experimental Hematology & Oncology|March 16, 2021
Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopeniaYuwen Chen, Jianda Hu, Yingyu Chen
Therapeutic Innovation & Regulatory Science|November 23, 2023
Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future DirectionsPei Li, Su Wang, Yuwen Chen
Sensors (Basel, Switzerland)|December 31, 2025
Joint Learning of Emotion and Singing Style for Enhanced Music Style UnderstandingYuwen Chen, Jing Mao, Rui-Feng Wang
Frontiers in Public Health|January 20, 2025
Controlling shareholders' equity pledge and corporate innovation investment-empirical analysis based on pharmaceutical manufacturingJiawen Li, Xingyu Zhao, Su Wang, et al.
Scientific Reports|June 13, 2018
(-)-Gochnatiolide B, synthesized from dehydrocostuslactone, exhibits potent anti-bladder cancer activity in vitro and in vivoYuwen Chen, Wenhua Li, Zhongqiu Zeng, et al.
Frontiers in Medicine|April 17, 2026
The impact of the 2019 revision of China's drug administration law on the innovative output of pharmaceutical and biotechnology enterprises-a quasi-natural experimental study using sharp regression discontinuity designYanan Zhu, Yongfei Liu, Yuwen Chen, et al.
Cell Biology and Toxicology|August 1, 2025
CD44-targeted therapy using mP6/Rg3 micelles inhibits oral cancer stem cell proliferation and migrationSijia Cai, Yuwen Chen, Changyu Chen, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 22, 2024
[Rapamycin and HPPH Co-Loaded Nanodrug Delivered via Dissolvable Microneedles to Treat Port-Wine Stains]Ying Hao, Runhao Xu, Mao Chen, et al.
Tumour Virus Research|January 20, 2025
How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infectionYuwen Chen, Nagayasu Egawa, Ke Zheng, et al.
Pageof 23